Paxmedica announces nasdaq closing bell ringing to celebrate initial public offering and autism awareness month

Broadcasting live on wednesday april 19th at 3:45 pm et tarrytown, ny, april 19, 2023 (globe newswire) -- via newmediawire – paxmedica, inc. (nasdaq: pxmd), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“apt”) for the treatment of disorders with intractable neurologic symptoms, today announced that chief executive officer howard weisman will ring the nasdaq stock market closing bell on wednesday april 19, 2023. this comes to celebrate paxmedica's listing of its common shares on the nasdaq capital market in august 2022 and april's autism awareness month.
PXMD Ratings Summary
PXMD Quant Ranking